Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis

Richard A. Rudick, Diane L. Cookfair, Nancy A. Simonian, Richard M. Ransohoff, John R. Richert, Lawrence D. Jacobs, Robert M. Herndon, Andres M. Salazar, Jill S. Fischer, Carl V. Granger, Donald E. Goodkin, Jack H. Simon, David M. Bartoszak, Dennis N. Bourdette, Jonathan Braiman, Carol M. Brownscheidle, Michael E. Coats, Stanley L. Cohan, David S. Dougherty, Revere P. KinkelMichele K. Mass, Frederick E. Munchsauer, Kathy O'Reilly, Roger L. Priore, Patrick M. Pullicino, Barbara J. Scherokman, Karl Wende, Bianca Weinstock-Guttman, Ruth Whitham

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Fingerprint

Dive into the research topics of 'Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences